Tag: GLP1

World Health Organization Recommends GLP-1 Drugs Like Ozempic For Obesity. Here’s What To Know

Obesity is a global epidemic that affects over a billion people worldwide, leading to serious health conditions such

WHO Unveils GLP-1 Guidelines | Scientific American

The World Health Organization (WHO) has recently released new guidelines for the use of GLP-1 weight-loss drugs in

GLP-1 Pill Fails to Slow Alzheimer’s Progression in Clinical Trial

The recent failure of Novo Nordisk's GLP-1 pill, semaglutide, to slow down the progression of Alzheimer's disease has

RFK Jr., GLP-1 study, aluminum in vaccines: Morning Rounds

This app wants to help truckers get healthy Did you know that out of the 3.5 million truckers

Andy Richter Credits GLP-1 Zepbound for DWTS Weight Loss

Andy Richter recently opened up about his weight loss journey on Dancing With the Stars, crediting part of

Microdosing GLP-1 drugs, vaping, FDA drama, : Morning Rounds

The Trump administration has announced that it will partially fund the Supplemental Nutrition Assistance Program (SNAP) for November,

Autism research, IVF care, GLP-1 side effects: Morning Rounds

Can a new scale really measure incessant thoughts about food? Ro, a telehealth giant, has introduced a new

Opinion: Trumps $150-per-month GLP-1 plan wont reach people like me

On October 16, President Trump pledged to reduce the cost of brand-name GLP-1 medications such as Ozempic and

New oral GLP-1 drugs could offer more options for weight loss

Oral weight loss medications are now a reality. Recent studies, published on September 16 and 17 in the

Smart Scales Are Dumb. ShapeScale Redefines Longevity In The GLP-1 Era

ShapeScale at home KREMER JOHNSON PHOTOGRAPHY With the Rise of GLP-1 Drugs Like Ozempic, ShapeScale’s 3D Body Scanner

As GLP-1 Drugs Take Off, Walmart Expands Specialty Pharmacy Delivery

Walmart is actively enhancing its delivery services for specialty medications, including crucial GLP-1 drugs like Ozempic and Zepbound,

Novo Nordisk reports second quarter earnings missing Wall Street estimates on slower GLP-1 sales

Novo Nordisk (NVO) stock took a hit in pre-market trading after the company reported a miss on both